[{"address1": "National Innovation Centre", "address2": "Suite 212a 2 4 Cornwallis Street Eveleigh", "city": "Sydney", "state": "NSW", "zip": "2015", "country": "Australia", "phone": "61 2 9209 4037", "fax": "61 2 9209 4037", "website": "https://www.claritypharmaceuticals.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.", "fullTimeEmployees": 69, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan John Taylor Ph.D.", "title": "Executive Chairman", "fiscalYear": 2025, "totalPay": 999022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Parker", "title": "CEO, MD & Executive Director", "fiscalYear": 2025, "totalPay": 521266, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Green BEc., CA", "title": "Chief Financial Officer", "fiscalYear": 2025, "totalPay": 323038, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Colin David Biggin Ph.D.", "title": "COO & Non-Independent Executive Director", "fiscalYear": 2025, "totalPay": 495383, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew  Harris BSc., M.B.A., Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2025, "totalPay": 127454, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Bennett", "title": "Head of People & Culture", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shaemus  Gleason", "title": "Executive Vice President of Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Othon  Gervasio", "title": "Chief Medical Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eva  Lengyelova", "title": "Executive Vice President of Clinical Development", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Vickery", "title": "Company Secretary", "fiscalYear": 2025, "totalPay": 106367, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 10, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.12, "open": 2.05, "dayLow": 2.05, "dayHigh": 2.12, "regularMarketPreviousClose": 2.12, "regularMarketOpen": 2.05, "regularMarketDayLow": 2.05, "regularMarketDayHigh": 2.12, "payoutRatio": 0.0, "beta": 1.33, "volume": 9700, "regularMarketVolume": 9700, "averageVolume": 5577, "averageVolume10days": 4120, "averageDailyVolume10Day": 4120, "bid": 1.95, "ask": 2.07, "bidSize": 500, "askSize": 400, "marketCap": 788500096, "fiftyTwoWeekLow": 0.842, "fiftyTwoWeekHigh": 6.398, "priceToSalesTrailing12Months": 83.32605, "fiftyDayAverage": 2.29668, "twoHundredDayAverage": 2.17576, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 597401472, "profitMargins": 0.0, "floatShares": 242762503, "sharesOutstanding": 371934016, "heldPercentInsiders": 0.24123, "heldPercentInstitutions": 0.17292, "impliedSharesOutstanding": 372024992, "bookValue": 0.281, "priceToBook": 7.5444837, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -64295436, "trailingEps": -0.13, "enterpriseToRevenue": 63.131, "enterpriseToEbitda": -8.669, "52WeekChange": -0.6102941, "SandP52WeekChange": 0.18469036, "quoteType": "EQUITY", "currentPrice": 2.12, "recommendationKey": "none", "totalCash": 84118352, "totalCashPerShare": 0.262, "ebitda": -68908944, "totalDebt": 0, "quickRatio": 9.077, "currentRatio": 9.693, "totalRevenue": 9462828, "revenuePerShare": 0.03, "returnOnAssets": -0.33764, "returnOnEquity": -0.54366, "grossProfits": 9462828, "freeCashflow": -33697940, "operatingCashflow": -54769024, "revenueGrowth": -0.216, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -8.231791, "financialCurrency": "AUD", "symbol": "CLRPF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "corporateActions": [], "regularMarketTime": 1757030400, "messageBoardId": "finmb_263530964", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 2.12, "marketState": "CLOSED", "hasPrePostMarketData": false, "fiftyDayAverageChange": -0.17668009, "fiftyDayAverageChangePercent": -0.076928474, "twoHundredDayAverageChange": -0.055760145, "twoHundredDayAverageChangePercent": -0.025627892, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "exchange": "PNK", "shortName": "Clarity Pharmaceuticals Ltd.", "longName": "Clarity Pharmaceuticals Ltd", "firstTradeDateMilliseconds": 1723728600000, "regularMarketChange": 0.0, "regularMarketDayRange": "2.05 - 2.12", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 5577, "fiftyTwoWeekLowChange": 1.2779999, "fiftyTwoWeekLowChangePercent": 1.5178145, "fiftyTwoWeekRange": "0.842 - 6.398", "fiftyTwoWeekHighChange": -4.278, "fiftyTwoWeekHighChangePercent": -0.66864645, "fiftyTwoWeekChangePercent": -61.02941, "earningsTimestampStart": 1755514740, "earningsTimestampEnd": 1756728000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.13, "displayName": "Clarity Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]